328 related articles for article (PubMed ID: 30093629)
1. SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis.
Li H; Tian Z; Qu Y; Yang Q; Guan H; Shi B; Ji M; Hou P
Oncogene; 2019 Jan; 38(3):345-359. PubMed ID: 30093629
[TBL] [Abstract][Full Text] [Related]
2. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.
Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P
Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956
[TBL] [Abstract][Full Text] [Related]
3. hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.
Zheng H; Yang L; Peng L; Izumi V; Koomen J; Seto E; Chen J
Mol Cell Biol; 2013 Dec; 33(24):4960-70. PubMed ID: 24126058
[TBL] [Abstract][Full Text] [Related]
4. ZNF677 Suppresses Akt Phosphorylation and Tumorigenesis in Thyroid Cancer.
Li Y; Yang Q; Guan H; Shi B; Ji M; Hou P
Cancer Res; 2018 Sep; 78(18):5216-5228. PubMed ID: 29997231
[TBL] [Abstract][Full Text] [Related]
5. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Serine-Threonine Kinase Akt Activation by NAD
Yu J; Qin B; Wu F; Qin S; Nowsheen S; Shan S; Zayas J; Pei H; Lou Z; Wang L
Cell Rep; 2017 Jan; 18(5):1229-1240. PubMed ID: 28147277
[TBL] [Abstract][Full Text] [Related]
7. LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β.
Zhao WJ; Zhu LL; Yang WQ; Xu SJ; Chen J; Ding XF; Liang Y; Chen G
Cancer Sci; 2021 Apr; 112(4):1624-1632. PubMed ID: 33540491
[TBL] [Abstract][Full Text] [Related]
8. Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.
Nin V; Escande C; Chini CC; Giri S; Camacho-Pereira J; Matalonga J; Lou Z; Chini EN
J Biol Chem; 2012 Jul; 287(28):23489-501. PubMed ID: 22553202
[TBL] [Abstract][Full Text] [Related]
9. DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.
Zannini L; Buscemi G; Kim JE; Fontanella E; Delia D
J Mol Cell Biol; 2012 Oct; 4(5):294-303. PubMed ID: 22735644
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of phosphorylated p70S6 kinase and Akt in papillary thyroid cancer tissues.
Miyakawa M; Tsushima T; Murakami H; Wakai K; Isozaki O; Takano K
Endocr J; 2003 Feb; 50(1):77-83. PubMed ID: 12733712
[TBL] [Abstract][Full Text] [Related]
11. A tumor-suppressing role of TSPYL2 in thyroid cancer: Through interacting with SIRT1 and repressing SIRT1/AKT pathway.
Zhang X; Wu X; Yao W; Wang YH
Exp Cell Res; 2023 Nov; 432(1):113777. PubMed ID: 37696385
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma.
Wu W; Zhang L; Lin J; Huang H; Shi B; Lin X; Huang Z; Wang C; Qiu J; Wei X
Oncotarget; 2016 Dec; 7(51):84416-84427. PubMed ID: 27793057
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of the deacetylase SIRT1 by DBC1.
Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W
Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502
[TBL] [Abstract][Full Text] [Related]
14. Sirt7 promotes adipogenesis in the mouse by inhibiting autocatalytic activation of Sirt1.
Fang J; Ianni A; Smolka C; Vakhrusheva O; Nolte H; Krüger M; Wietelmann A; Simonet NG; Adrian-Segarra JM; Vaquero A; Braun T; Bober E
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8352-E8361. PubMed ID: 28923965
[TBL] [Abstract][Full Text] [Related]
15. Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism.
Hubbard BP; Loh C; Gomes AP; Li J; Lu Q; Doyle TL; Disch JS; Armour SM; Ellis JL; Vlasuk GP; Sinclair DA
Cell Cycle; 2013 Jul; 12(14):2233-40. PubMed ID: 23892437
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT1 and Ras/Akt pathways.
Zhang JG; Zhao G; Qin Q; Wang B; Liu L; Liu Y; Deng SC; Tian K; Wang CY
Pancreatology; 2013; 13(2):140-6. PubMed ID: 23561972
[TBL] [Abstract][Full Text] [Related]
17. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
18. Positive Feedback Loops Between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis.
Zhang Y; Sui F; Ma J; Ren X; Guan H; Yang Q; Shi J; Ji M; Shi B; Sun Y; Hou P
J Clin Endocrinol Metab; 2017 Feb; 102(2):613-624. PubMed ID: 27732334
[TBL] [Abstract][Full Text] [Related]
19. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation.
Barber MF; Michishita-Kioi E; Xi Y; Tasselli L; Kioi M; Moqtaderi Z; Tennen RI; Paredes S; Young NL; Chen K; Struhl K; Garcia BA; Gozani O; Li W; Chua KF
Nature; 2012 Jul; 487(7405):114-8. PubMed ID: 22722849
[TBL] [Abstract][Full Text] [Related]
20. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
